08th week of 2014 patent applcation highlights part 43 |
Patent application number | Title | Published |
20140051822 | Dehydrogenative Silylation and Crosslinking Using Cobalt Catalysts - Disclosed herein are cobalt complexes containing terdentate pyridine di-imine ligands and their use as efficient and selective dehydrogenative silylation and crosslinking catalysts. | 2014-02-20 |
20140051823 | METHOD FOR PRODUCING ALIPHATIC POLYESTER HAVING INCREASED MOLECULAR WEIGHT - The problem to be solved by the present invention is to provide a method for continuously and effectively producing an aliphatic polyester having an increased molecular weight which prevents evaporation of diisocyanate at the step of mixing the diisocyanate with the aliphatic polyester prepolymer in a molten state at a temperature not lower than the melting point of the prepolymer and enables uniform mixing of the diisocyanate with the aliphatic polyester prepolymer. In order to solve this problem, the present invention provides a method for producing an aliphatic polyester having an increased molecular weight comprising the steps of:
| 2014-02-20 |
20140051824 | BIO-BASED PRE-REACTED PRODUCT OF A POLYOL AND A MONOMERIC OR POLYMERIC POLYCARBOXYLIC ACID - An environmentally friendly, pre-reacted product of a polyol and monomeric or polymeric polycarboxylic acid or polyglycerol is provided. The pre-reacted product may include glycerol and esters of citric acid such a monoglyceryl citrate, diglyceryl citrate, and triglyceryl citrate as well as other citric acid-based esters. The pre-reacted product, when used in a binder, helps to speed the crosslinking reaction, induces faster water evaporation, decreases the viscosity of the binder, helps to reduce the amount of water needed for application of the binder, and decreases tackiness. The pre-reacted product may be used, for example, in the formation of insulation materials and non-woven chopped strand mats. | 2014-02-20 |
20140051825 | POLYMERIC PIEZOELECTRIC MATERIAL, AND PROCESS FOR PRODUCING THE SAME - The invention provides a polymeric piezoelectric material including a helical chiral polymer having a weight-average molecular weight of from 50,000 to 1,000,000 and having optical activity, wherein a crystallinity of the material measured by a DSC method is from 20% to 80%, and a product of a standardized molecular orientation MORc measured by a microwave transmission type molecular orientation meter based on a reference thickness of 50 μm and the crystallinity is from 25 to 250. | 2014-02-20 |
20140051826 | NOVEL COMPOUND FOR CARRIER TRANSPORT, ELEMENT AND ELECTRONIC DEVICE USING THE SAME - The present invention provides a compound of formula I | 2014-02-20 |
20140051827 | CONJUGATED POLYMER, INSOLUBILIZED POLYMER, ORGANIC ELECTROLUMINESCENCE ELEMENT MATERIAL, COMPOSITION FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, POLYMER PRODUCTION PROCESS, ORGANIC ELECTROLUMINESCENCE ELEMENT, ORGANIC EL DISPLAY AND ORGANIC EL LIGHTING - An object of the present invention is to provide a conjugated polymer which has a high hole transportability and is excellent in solubility and depositability. Another object of the present invention is to provide an organic electroluminescence element which is capable of low voltage driving and has a high luminous efficiency and drive stability. The conjugated polymer of the present invention is a conjugated polymer containing a specific structure as the repeating unit, where the conjugated polymer contains an insolubilizing group as a substituent, the weight average molecular weight (Mw) is 20,000 or more and the dispersity (Mw/Mn) is 2.40 or less. | 2014-02-20 |
20140051828 | METHODS FOR PREPARING INTERNALLY CONSTRAINED PEPTIDES AND PEPTIDOMIMETICS - The present invention relates to a method for preparing a peptide having a stable, internally constrained alpha-helical, beta-sheet/beta-turn, | 2014-02-20 |
20140051829 | AXMI-205 PESTICIDAL GENE AND METHOD FOR ITS USE - Compositions and methods for conferring pesticidal activity to bacteria, plants, plant cells, tissues and seeds are provided. Compositions comprising a coding sequence for pesticidal polypeptides are provided. The coding sequences can be used in DNA constructs or expression cassettes for transformation and expression in plants and bacteria. Compositions also comprise transformed bacteria, plants, plant cells, tissues, and seeds. In particular, isolated pesticidal nucleic acid molecules are provided. Additionally, amino acid sequences corresponding to the polynucleotides are encompassed. In particular, the present invention provides for nucleic acid molecules comprising nucleotide sequences encoding the amino acid sequence shown in SEQ ID NO:2, 3, or 4, the nucleotide sequence set forth in SEQ ID NO:1, 9, 10, or 11, as well as variants and fragments thereof. | 2014-02-20 |
20140051830 | In-Process Control for the Manufacture of Glatiramer Acetate - The present disclosure provides methods for manufacturing or producing glatiramer acetate having a Mp of 5000-9000 Da. These methods include: polymerizing N-carboxy anhydrides of L-alanine, benzyl-protected L-glutamic acid, trifluoroacetic acid (TFA)-protected L-lysine, and L-tyrosine to generate a sample comprising intermediate-1; treating the sample comprising intermediate-1 to partially depolymerize the protected copolymer and deprotect benzyl-protected L-glutamic acid, measuring the viscosity of the sample comprising intermediate-1 during the treatment, and ending the treatment when the viscosity of the sample is within an endpoint range, thereby generating a sample comprising intermediate-2; treating the sample comprising intermediate-2 to deprotect TFA-protected L-lysine, thereby generating intermediate-3; further processing the intermediate-3 to generate a sample glatiramer acetate; and purifying the glatiramer acetate to generate a composition comprising purified glatiramer acetate having a Mp of 5000-9000 Da. | 2014-02-20 |
20140051831 | METHOD FOR ISOLATING OSTEOPONTIN USING FEEDS CONTAINING CMP OR CASEIN SPECIES - The present invention pertains to a method for isolating osteopontin from a milk-derived feed containing caseino macropeptide and/or free beta casein, such as e.g. a feed based on milk serum or sweet whey. Particularly, the present method involves the use of a narrow window of pH and specific conductance of the milk-derived feed, which surprisingly has proven to provide a very efficient isolation of osteopontin from chemically complex feeds. | 2014-02-20 |
20140051832 | METHOD FOR THE PRODUCTION OF RECOMBINANT HUMAN FACTOR VIII - The object of the present invention is to provide methods for the production of recombinant human Factor VIII, employing specific endoproteases, thus assuring full proteolytic processing of said factor even during its biosynthesis, consequently avoiding additional purification steps. Other objects of the present invention are the recombinant human Factor VIII as obtained by said methods, pharmaceutical compositions, related uses and therapeutic methods. | 2014-02-20 |
20140051833 | Readily Isolated Bispecific Antibodies with Native Immunoglobulin Format - The invention relates to antigen-binding proteins or antibodies having heterodimers of heavy chains, i.e., two immunoglobulin heavy chains that differ by at least one or two amino acid(s) that allows for isolation of the antigen-binding protein based on a differential affinity of an immunoglobulin heavy chain and a modified/mutated immunoglobulin heavy chain toward an affinity reagent. The invention also relates antigen-binding proteins, including bispecific antibodies, having IgG CH1 regions with different affinities with respect to affinity reagent(s) that allows rapid isolation by differential binding of the IgG regions to the affinity reagent(s). | 2014-02-20 |
20140051834 | Incretin Receptor Ligand Polypeptide Fc-Region Fusion Polypeptides And Conjugates With Altered Fc-Effector Function - Herein is reported an Fc-region fusion polypeptide or Fc-region conjugate comprising one to four incretin receptor ligand polypeptides and a variant human Fc-region with a mutation of the amino acid residue at position 329 and at least one further mutation of at least one amino acid selected from the group comprising amino acid residues at position 228, 233, 234, 235, 236, 237, 297, 318, 320, 322 and 331 to a different residue, wherein the residues in the Fc-region are numbered according to the EU index of Kabat and its use as a medicament. | 2014-02-20 |
20140051835 | Process and Methods for Efficient Manufacturing of Highly Pure Asymmetric Antibodies in Mammalian Cells - The present invention provides a process and methods for producing asymmetric antibodies in a mammalian expression system. The asymmetric antibodies are transiently or stably expressed and in cells that stably express the asymmetric antibody, following a rapid 2-step process of stable pool to clone, a highly pure asymmetric antibody expressing clone can be identified at a success frequency that permits for screening of tens of clones rather than thousands. The asymmetric antibodies are produced at a high titre and with a high level of purity with no contaminating homodimer antibodies following protein A purification with a step yield of near 100%. Typical downstream purification processes employ standard hydrophobic interaction chromatography (HIC) and/or cation exchange (CEX) resins and the antibody is stable within a wide dynamic range of buffer pH (4-8) and within the requirements for manufacturing antibodies for pre-clinical and clinical applications. | 2014-02-20 |
20140051836 | Modified Fc Proteins Comprising Site-Specific Non-Natural Amino Acid Residues, Conjugates of the Same, Methods of Their Preparation and Methods of Their Use - Provided herein are modified Fc proteins comprising non-natural amino acid residues at site-specific positions, conjugates of the modified Fc proteins for therapy or diagnosis, compositions comprising the modified Fc proteins and conjugates thereof, methods of their production and methods of their use. The modified Fc proteins and conjugates are useful for methods of treatment and prevention, methods of detection and methods of diagnosis. | 2014-02-20 |
20140051837 | AXMI-205 PESTICIDAL GENE AND METHOD FOR ITS USE - Compositions and methods for conferring pesticidal activity to bacteria, plants, plant cells, tissues and seeds are provided. Compositions comprising a coding sequence for pesticidal polypeptides are provided. The coding sequences can be used in DNA constructs or expression cassettes for transformation and expression in plants and bacteria. Compositions also comprise transformed bacteria, plants, plant cells, tissues, and seeds. In particular, isolated pesticidal nucleic acid molecules are provided. Additionally, amino acid sequences corresponding to the polynucleotides are encompassed. In particular, the present invention provides for nucleic acid molecules comprising nucleotide sequences encoding the amino acid sequence shown in SEQ ID NO:2, 3, or 4, the nucleotide sequence set forth in SEQ ID NO:1, 9, 10, or 11, as well as variants and fragments thereof. | 2014-02-20 |
20140051838 | NUCLEIC ACID AND CORRESPONDING PROTEIN ENTITLED 161P2F10B USEFUL IN TREATMENT AND DETECTION OF CANCER - A novel gene 0161P2F10B (also designated 161P2F10B) and its encoded protein, and variants thereof, are described wherein 161P2F10B exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, 161P2F10B provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 161P2F10B gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 161P2F10B can be used in active or passive immunization. | 2014-02-20 |
20140051839 | Process for Reduction and/or Removal of FXI and FXIa from Solutions Containing said Coagulation Factors - A process for reduction and/or removal of FXI and FXIa from a source solution containing said coagulation factors and as main components immunoglobulins comprising the following steps:
| 2014-02-20 |
20140051840 | ARSENIC COMPLEXES FOR POTENTIAL DIAGNOSTIC APPLICATIONS - The present invention provides radioactive arsenic complex useful in diagnostic and therapeutic applications and methods for forming those arsenic complexes. | 2014-02-20 |
20140051841 | PROCESS FOR PURIFYING RECOMBINANT PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN - The present invention relates to processes for purifying high-quality recombinant | 2014-02-20 |
20140051842 | POLYNUCLEOTIDE AND POLYPEPTIDE SEQUENCE AND METHODS THEREOF - The present disclosure relates to a field of recombinant DNA therapeutics. It involves the bio-informatics design, synthesis of artificial gene for human insulin precursor including leader peptide coding sequence, cloning in an expression vector and expression in an organism, preferably | 2014-02-20 |
20140051843 | METHODS AND COMPOSITIONS FOR DETECTING PROMOTER ACTIVITY AND EXPRESSING FUSION PROTEINS - The present invention provides nucleic acid molecules comprising one or more nucleic acid sequences encoding a polypeptide having a detectable activity. The present invention also provides methods of joining such nucleic acid molecules to nucleic acid molecules to be assayed for promoter activity. The present invention also relates to methods of preparing fusion proteins comprising a polypeptide of interest and a polypeptide having a detectable activity. | 2014-02-20 |
20140051844 | Nucleic Acid Purification - Methods and composition for nucleic acid isolation are provided. In one embodiment, a method is provided for nucleic acid purification from biological samples, such as whole blood samples, extracted with phenol-based denaturing solvents, which does not require phase separation or nucleic acid precipitation. Methods according to the invention may also be used for of small RNAs (e.g., siRNAs or miRNAs) purification and are amenable to automation. | 2014-02-20 |
20140051845 | Method Involving 1-Benzotriazolyl Carbonate Esters of Poly(ethylene glycol) - The invention provides for preparing a polymer-active agent conjugate, the method comprising the steps of reacting an amino acid derivative with a biologically active agent under conditions to form a polymer-active agent conjugate. | 2014-02-20 |
20140051846 | 2'-O-AMINOOXYMETHYL NUCLEOSIDE DERIVATIVES FOR USE IN THE SYNTHESIS AND MODIFICATION OF NUCLEOSIDES, NUCLEOTIDES AND OLIGONUCLEOTIDES - Disclosed are O-protected compounds of the formula (I): wherein B is an optionally protected nucleobase, and R | 2014-02-20 |
20140051847 | METHOD FOR ISOLATING DNA - The present invention provides a method for the isolation of nucleic acid from microbial cells in an environmental sample. The method includes preparing a suspension of the environmental sample, lysing the suspended sample with a buffered solution, adding sodium dodecylsulfate solution to the lysed suspended sample, carrying out solvent extraction and separation to obtain an aqueous phase, reacting the aqueous phase with solvents to generate an insoluble precipitate containing nucleic acid, and isolating the nucleic acid therefrom, thereby releasing high molecular weight nucleic acid pellets from the cells. | 2014-02-20 |
20140051848 | NUCLEOTIDES AND NUCLEOSIDES AND METHODS FOR THEIR USE IN DNA SEQUENCING - The present invention relates generally to labeled and unlabeled cleavable terminating groups and methods for DNA sequencing and other types of DNA analysis. More particularly, the invention relates in part to nucleotides and nucleosides with chemically cleavable, photocleavable, enzymatically cleavable, or non-photocleavable groups and methods for their use in DNA sequencing and its application in biomedical research. | 2014-02-20 |
20140051849 | HEMOSTATIC COMPOSITIONS AND THERAPEUTIC REGIMENS - The present invention relates generally to the field of hemostasis, including methods, compositions, and devices that can be employed to treat wounds. More specifically the present invention relates to hemostatic compositions that reduce the need for, and cost of, nursing care of patients with chronic wounds by reducing the frequency of wound dressing changes. | 2014-02-20 |
20140051850 | LACTOSE CRYSTALLISATION - The invention relates to a method of crystallising lactose from a lactose-containing liquid comprising the steps of providing a lactose-containing liquid comprising less than 80% by weight total solids, providing an evaporator system that comprises a heat exchanger and an evaporation vessel, the heat exchanger comprising a tube or tubes that define a flowpath having an inlet and an outlet, heating the lactose-containing liquid in the heat exchanger to about 50 to about 90° C. such that the lactose-containing liquid passes along the flowpath by forced circulation or thermo-siphoning, concentrating the lactose-containing liquid in the evaporation vessel, to generate crystallised lactose in the lactose-containing liquid in the evaporator system. | 2014-02-20 |
20140051851 | [18F] Fluoride Cryptate Complexes for Radiolabeling Fluorinations - The present invention claims complexing [ | 2014-02-20 |
20140051852 | Process for Synthesizing Oxidized Lactam Compounds - The invention provides a method for the synthesis of dehydrogenated lactam drugs of Formula I: | 2014-02-20 |
20140051853 | Salt forms of 4-(4-Methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-- 2-ylamino)phenyl]-benzamide - The present invention relates to acid addition salts of 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide, which are selected from the group consisting of a tartrate salt, such as a (D)(−) tartrate salt or a (L)(+) tartrate salt, a hydrochloride salt, a citrate salt, a malate salt, a fumarate salt, a succinate salt, a benzoate salt, a benzenesulfonate salt, a pamoate salt, a formate salt, a malonate salt, a 1,5-naphthalenedisulfonate salt, a salicylate salt, a cyclohexanesulfamate salt, a lactate salt, a mandelate salt, aq glutarate salt, an adipate salt, a squarate salt, a vanillate salt, an oxaloacetate salt, an ascorbate salt and a sulfate salt. | 2014-02-20 |
20140051854 | PROCESS FOR THE PREPARATION OF KEY INTERMEDIATES FOR THE SYNTHESIS OF STATINS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF - The invention relates to commercially viable process for the synthesis of key intermediates for the preparation of statins, in particular Rosuvastatin and Pitavastatin or respective pharmaceutically acceptable salts thereof. A new simple and short synthetic route for key intermediates is presented which benefits from the use of cheap and readily available starting materials, by which the conventionally most frequently used DIBAL-H as reducing agent can be avoided. | 2014-02-20 |
20140051855 | PENTA-SUBSTITUTED TETRAHYDROPYRIMIDINES WITH AGGREGATION-INDUCED EMISSION CHARACTERISTICS AND PREPARATION METHOD AND USE THEREOF - The present invention provides a series of penta-substituted tetrahydropyrimidines with aggregation-induced emission (AIE) characteristics and preparation method and use thereof. The AIE penta-substituted tetrahydropyrimidines have structures shown as formula (I). R | 2014-02-20 |
20140051856 | NOVEL SALTS OF DPP-IV INHIBITOR - The present invention discloses new salts of (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]-triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine i.e. gentisate, adipate and trifluoro acetic acid salts. The invention also describes the new. crystalline and amorphous forms of (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]-triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine gentisate. The present invention also discloses novel crystalline salt form of (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]-triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine hydrochloride and novel crystalline and amorphous salt forms of besylate and process for their preparation and isolation. | 2014-02-20 |
20140051857 | HETEROCYCLIC COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS - A compound represented by the formula (1): | 2014-02-20 |
20140051858 | PREPARING METHOD OF SOLID CARBAMIC ACID DERIVATIVES - The present disclosure relates to a preparation method for powder of a carbamic acid derivative, which includes reacting a liquid amine derivative with carbon dioxide at a temperature in a range of from about −30° C. to about 500° C. at a pressure in a range of from about 0.3 MPa to about 100 MPa. In addition, the present disclosure relates to a reduction method for powder of a carbamic acid derivative to a liquid amine derivative and carbon dioxide, which includes dissolving powder of the carbamic acid derivative prepared in a solvent; refluxing the carbamic acid derivative at a temperature in a range of from about 30° C. to about 100° C.; and evaporating the solvent. The preparation method for a carbamic acid derivative powder according to the present disclosure enables easy conversion into pure powder of solid carbamic acid derivative without by-products and can remarkably reduce time and energy required for solidification by reacting carbon dioxides and amines with carbon dioxides in high pressure conditions without the use of a solvent. In addition, the prepared solid compounds can be used as a liquid amine substitute or used in a carbamic acid derivative form as necessary. | 2014-02-20 |
20140051859 | NOVEL NI COMPLEX AND ITS DERIVATIVES, PRODUCING METHOD, AND THE USE THEREOF AS AN ANTIOXIDANT - The present invention relates to a novel nickel complex and its derivatives, which mimic the active site of Ni-containing superoxide dismutase (NiSOD). The five-coordinate Ni(II) and Ni(III) complexes or their derivatives, and six-coordinate derivatives have the following structures of formula (I) and (II): | 2014-02-20 |
20140051860 | PROCESS FOR PRODUCING A NITROGEN-CONTAINING CARBON ALLOY - A nitrogen-containing carbon alloy obtained by baking an organic material having a nitrogen-containing crystalline organic compound having a molecular weight of 60 to 2000, wherein the nitrogen-containing crystalline organic compound excludes a nitrogen-containing metal complex. | 2014-02-20 |
20140051861 | PROCESS FOR PREPARING OXYMORPHONE, NALTREXONE, AND BUPRENORPHINE - Methods are provided which include converting oripavine to other opiates, including converting oripavine to naltrexone, buprenorphine, 14-hydroxymorphinone and/or converting 14-hydroxymorphinone to oxymorphone. Purification and salt formation are optionally included. | 2014-02-20 |
20140051862 | 5-MEMBERED RING HETEROAROMATIC DERIVATIVES HAVING NPY Y5 RECEPTOR ANTAGONISTIC ACTIVITY - This invention provides new compounds having NPY Y5 antagonistic activity. The present inventors found that a compound of the formula (I): | 2014-02-20 |
20140051863 | FLUORESCENT PROBES FOR DETECTION OF COPPER - The invention provides fluorescent sensors for the selective detection of a metal such as copper. The sensors may be considered to be derivatives of cyanine, fluorescein, rhodamine, rhodol, Tokyo green, or BODIPY. The sensors find particular use in detecting copper in cells and living animals. | 2014-02-20 |
20140051864 | QUATERNARY AMMONIUM DIPHENYLMETHYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS - The invention provides compounds of formula I: | 2014-02-20 |
20140051865 | DESCRIPTION NOVEL COMPUND, METHOD OF PRODUCING THE COMPOUND, ORGANIC SEMICONDUCTOR MATERIAL AND ORGANIC SEMICONDUCTOR DEVICE - There are provided a novel compound having a good field mobility, a method of producing of the compound, an organic semiconductor material containing the novel compound, and an organic semiconductor device. The novel compound which is represented by the following general formula (1), (2), (3) or (4) (where Z represents a sulfur atom or a selenium atom, and R represents a hydrogen atom, an alkyl group or a phenyl group in general formulae) has a structure having two benzene rings of naphthalene bonded with a thiophene ring and a selenophene ring, respectively. These compounds have a conjugate system in molecules due to an interaction between π orbitals, and show a strong molecular interaction through a sulfur atom or a selenium atom contained in a thiophene ring or a selenophene ring in each molecule, thereby having a good field mobility. | 2014-02-20 |
20140051866 | SYNTHESIS OF AN ANTIVIRAL COMPOUND - The present disclosure provides a processes for the preparation of a compound of Formula I: | 2014-02-20 |
20140051867 | SYNTHESIS OF AN ANTIVIRAL COMPOUND - The present disclosure provides processes for the preparation of a compound of Formula I: | 2014-02-20 |
20140051868 | Methods and Systems For Synthesis of Ultrabright Silica Particles Capable of Measuring Temperature - Ultrabright fluorescent silica particles that can take stable temperature measurements, and methods of their manufacture. The particles have encapsulated fluorescent substances, some of which can exhibit altering fluorescent characteristics depending on temperature. The particles function as a thermometer allowing one to measure the temperature of the environment. A ratio of the fluorescent peaks in the fluorescent spectrum of each particle depends on temperature, but is dependent on neither the amount of exciting light nor the size of the particles. Further, the particle size can be confined to the range of 8 nm to 100 μm. | 2014-02-20 |
20140051869 | CONTINUOUS PROCESS FOR THE PRODUCTION OF BETA-KETO ESTERS BY CLAISEN CONDENSATION - A continuous process for producing compounds having the general formula (6) is provided: | 2014-02-20 |
20140051870 | CYCLOPROPENYLIDENE-STABILIZED PHOSPHENIUM CATIONS - Phosphenium compounds with the general formula I: | 2014-02-20 |
20140051871 | RUTHENIUM-DIAMINE COMPLEX AND METHOD FOR PRODUCING OPTICALLY ACTIVE COMPOUND - Provided is a ruthenium complex that is represented by general formula (1*) and is useful as an asymmetric reduction catalyst. | 2014-02-20 |
20140051872 | CATALYSTS FOR HYDRODEOXYGENATION OF OXYGENATED HYDROCARBONS - The present invention provides catalysts, methods, and reactor systems for converting oxygenated hydrocarbons to oxygenated compounds. The invention includes methods for producing cyclic ethers, monooxygenates, dioxygenates, ketones, aldehydes, carboxylic acids, and alcohols from oxygenated hydrocarbons, such as carbohydrates, sugars, sugar alcohols, sugar degradation products, and the like, using catalysts containing palladium, molybdenum, tin, and tungsten. The oxygenated compounds produced are useful in the production of liquid fuels, chemicals, and other products. | 2014-02-20 |
20140051873 | METHODS FOR FURFURAL PRODUCTION FROM BRANCHED NON-FERMENTABLE SUGARS IN STILLAGE OR SYRUP - Furfural is obtained selectively and in good purity from non-fermentable branched sugars found in soluble waste streams of lignocellulosic biomass. In a monophasic method, stillage or syrup is contacted with water and an acid catalyst under suitable reaction conditions to convert the branched non-fermentable branched sugars to furfural. Additionally, the stillage or syrup can be treated with a water-immiscible organic solvent to form a biphasic mixture comprising an aqueous phase and an organic phase. The furfural that is produced preferentially partitions into the organic phase, from which it may be recovered. | 2014-02-20 |
20140051874 | METHOD FOR PRODUCING FIVE-MEMBERED RING-CONTAINING COMPOUND - The present invention provides a method that allows production of stereospecific and asymmetrical five-membered ring-containing compounds serving as synthetic intermediates for formation of five-membered rings of prostaglandins and the like, with high yield and excellent stereoselectivity in terms of diastereoselectivity and enantioselectivity in a short process without requiring troublesome procedures such as optical resolution. The method for producing a five-membered ring-containing compound includes a cyclization step of condensing and cyclizing an α,β-unsaturated nitro compound represented by the following chemical formula (I) with a 1,4-butanedione compound, in the presence of a catalyst formed by a compound having a pyrrolidine ring and an optically active α-carbon relative to the nitrogen on the ring, in a water-insoluble organic solvent and/or a non-oxygen atom-containing water-soluble organic solvent so as to produce the five-membered ring-containing compound represented by the following chemical formula (II). | 2014-02-20 |
20140051875 | CRYSTALLINE FORM OF MAXACALCITOL - The present invention relates to maxacalcitol hydrate, a new crystalline form of maxacalcitol, with superior technical properties e.g. in the manufacture of crystal suspension formulations, and with superior stability properties. | 2014-02-20 |
20140051876 | METHOD FOR MANUFACTURING PHOSPHONOCROTONIC ACID DERIVATIVE - Provided is a method of manufacturing a high quality phosphonocrotonic acid derivative. | 2014-02-20 |
20140051877 | EICOSAPENTAENOIC ACID (EPA) AS POLYUNSATURATED FREE FATTY ACID IN ITS DIRECTLY COMPRESSIBLE POWDER FORM AND PROCESS OF ISOLATION THEREOF - The present invention provides Eicosapentaenoic acid (EPA) in its free fatty acid form and a process of isolation thereof from oils and fats of natural origin having Eicosapentaenoic acid (EPA) attached to triglycerides. The EPA isolated using the process of the present invention is in free flowing powder form which is directly compressible. Further, the EPA in powder form is free from triglycerides. The EPA powder of the present invention has purity more than 90%. The EPA in its free fatty acid powder form offers excellent bioavailability and stability at room temperature. | 2014-02-20 |
20140051878 | Metal Complexes with N-Aminoamidinate Ligands - The invention relates to new metal complexes having N-aminoamidinate ligands, more particularly metal complexes having N,N′-bis(dimethylamino)acetamidinate, N,N′-bis(dimethylamino)formamidinate, N-dimethylaminoacetamidinate or N-dimethylamino-N′-isopropyl-acetamidinate ligands as well as to their preparation and use. The metal complexes are characterized by a five-membered chelate ring. The metal complexes are formed with the metals from the main groups of the PTE, but also with transition-group elements such as tantalum (Ta), iron (Fe), cobalt (Co), nickel (Ni), copper (Cu) or zinc (Zn), and also with precious metals such as palladium (Pd). | 2014-02-20 |
20140051879 | BIODEGRADABLE PHOSPHOESTER POLYAMINES - Novel biodegradable phosphoester polyamines are disclosed. The biodegradable phosphoester polyamines may be utilized as cross-linkers for sprayable compositions which may be used as tissue adhesives or sealants. | 2014-02-20 |
20140051880 | METHOD FOR PREPARING DIALKYL CARBONATE - Disclosed is a method for preparing a dialkyl carbonate, in which a dialkyl carbonate such as dimethyl carbonate is economically prepared in an environmentally-friendly manner at a higher yield while reducing generation of a by-product. The method for preparing the dialkyl carbonate includes reacting urea, an alkyl carbamate having 1 to 3 carbon atoms, or a mixture thereof with a monovalent alcohol having 1 to 3 carbon atoms in the presence of a room temperature ionic liquid and a catalyst including a salt of a transition metal or a rare earth metal. | 2014-02-20 |
20140051881 | PROCESS FOR PREPARATION OF DICYANOCARBOXYLATE DERIVATIVES - The present disclosure provides a process for preparing 2,3-dicyanopropionic acid ester of formula (I); said process comprising the following steps: i) treating an alkali metal cyanide dissolved in a solvent with a solution of 2-cyano-2-propenoic acid ester of formula (II) at a temperature ranging between 0° C. and 50° C. for a time period ranging between 2 hours and 15 hours followed by cooling below 20° C. to obtain a sodium salt of 2,3-dicyanopropionic acid ester of formula (I); and | 2014-02-20 |
20140051882 | METHOD OF PURIFICATION OF PROSTAGLANDINS INCLUDING FLUORINE ATOMS BY PREPARATIVE HPLC - The present invention discloses a method of purification of prostaglandins including fluorine atoms by using preparative HPLC. Tafluprost and Travoprost are prostaglandins including fluorine. The chemical structure of the impurities in crude Tafluprost and crude Travoprost also contain fluorine, therefore, the removal of the impurities is difficult. Purification by using preparative high performance liquid chromatography (HPLC) can achieve high-quality liquid bulk drugs. | 2014-02-20 |
20140051883 | SYNTHESIS OF MOLECULAR SIEVES FOR MODIFYING THE SURFACES OF NANOPARTICLES HAVING AMPHOTERIC IONS, AND APPLICATION THEREOF - The present invention relates to a surface modification method for improving the dispersion of nanoparticles, and to nanoparticles having improved dispersion properties prepared by the method. More particularly, the present invention relates to a method in which amphoteric compounds are bonded to the surfaces of nanoparticles to improve dispersion at the surfaces of nanoparticles. The present invention also relates to nanoparticles using the method. Both anions and cations are formed on the surfaces of the nanoparticles according to the present invention, and therefore the nanoparticles are electrically stable so as to achieve stability in a wide pH range, are stably dispersed in the event of a high concentration of salts, and the non-specific adsorption thereof is reduced. Novel specific substances or sensors having minimized non-specific adsorption may be produced using the nanoparticles of the present invention. | 2014-02-20 |
20140051884 | PRODUCTION OF AROMATIC CARBOXYLIC ACIDS - An applicator instrument ( | 2014-02-20 |
20140051885 | CATALYST STABILITY IN CARBONYLATION PROCESSES - A method for stabilizing a carbonylation catalyst with carbon monoxide recovered from a gaseous stream derived from a carbonylation reaction. The carbon monoxide enriched stream is fed downstream of the carbonylation reactor, preferably to a flasher or light ends column, to enhance catalyst stability throughout the process. | 2014-02-20 |
20140051886 | PROCESS FOR PREPARING METHACRYLIC ACID - The present invention relates to a process for preparing methacrylic acid based on the hydrolysis of methacrylic esters. | 2014-02-20 |
20140051887 | PHARMACEUTICALLY ACCEPTABLE COCRYSTALS OF N-[2-(7-METHOXYL-1-NAPHTYL)ETHYL]ACETAMIDE AND METHODS OF THEIR PREPARATION - The present invention relates to novel solid forms of agomelatine (I), specifically novel phaamaceutically acceptable cocrystals thereof, as well as to methods of preparing them. Three pharmaceutically acceptable cocrystals of (I) that have physico-chemical properties acceptable for pharmaceutical development were obtained. | 2014-02-20 |
20140051888 | NOVEL STEREOISOMERIC MIXTURES, SYNTHESIS AND USES THEREOF - A novel stereochemical mixture of 1,6-diaryl-2,5-diaminohexanes, such as a mixture of stereoisomers of 1,6-diphenylhexane-2,5-diamine, is described. Also described are methods of preparing stereochemically pure 1,6-diaryl-2,5-diaminohexanes, and particularly stereochemically pure 1,6-diphenyl-2,5-diaminohexane. Also described is the use of both the mixture of stereoisomers and the individual stereoisomers. | 2014-02-20 |
20140051889 | ISOMERIZATION OF OLEFINIC COMPOUNDS - The present invention relates to a process for preparing an olefinically unsaturated phosphonium salt having at least two olefinic double bonds, of which one double bond has a Z or cis conformation and the second or a further double bond an E conformation, from an olefinically unsaturated phosphonium salt having at least two olefinic double bonds of different configuration compared to the target compound, and both especially have an all-E or all-trans conformation. In addition, the invention provides for the use of the compound obtained by the process for provision of terpenoid substances as medicaments. | 2014-02-20 |
20140051890 | PROCESS FOR PREPARING METHYLMERCAPTOPROPIONALDEHYDE - A process for preparing methylmercaptopropionaldehyde in a single reaction unit, is provided. According to the preferred embodiment, the process comprises, simultaneously contacting a gaseous mixture comprising acrolein with a liquid mixture comprising methylmercaptopropionaldehyde, methyl mercaptan, a catalyst and methylmercaptopropionaldehyde methyl thiohemiacetal in the reactive absorber; absorbing the acrolein from the gaseous mixture into the liquid mixture; reacting the absorbed acrolein with the methyl mercaptan or the methylmercaptopropionaldehyde methyl thiohemiacetal to obtain methylmercapto-propionaldehyde; removing gaseous impurities and by-products from the liquid mixture; and separating the obtained methylmercaptopropionaldehyde product from the reactive absorber, directing a portion of the separated product to storage or further processing and recycling the remaining portion to the reactive absorber; wherein the methyl mercaptan optionally comprises dimethyl sulfide or dimethyl ether. | 2014-02-20 |
20140051891 | PROCESS TO PURIFY DIALKYL SULFIDES - The invention relates to new processes to prepare low odor dialkyl sulfides, the low odor dialkyl sulfides obtainable by these processes and to methods of using these low odor dialkyl sulfides. Moreover, the invention relates to a process to prepare dialkyl sulfide borane complexes of high purity, the dialkyl sulfide borane complexes obtainable by this process and to a process for enantioselective reductions employing these dialkyl sulfide borane complexes of high purity as reducing agent. | 2014-02-20 |
20140051892 | Process for chemical synthesis from an alkenone made from a halogenated precursor - Process for synthesizing a chemical, in particular an agriculturally or pharmaceutically active compound, including: a first step comprising reacting a carboxylic acid halide with a vinyl ether to prepare a halogenated precursor of an alkenone; a second step comprising eliminating hydrogen halide from such precursor to form an alkenone, preferably by thermolysis under specific conditions; and a third step which uses the formed alkenone as a building block to synthesize the chemical. First step may be done in a liquid reaction medium comprising an alkenone or a halogenated alkenone precursor, or in a liquid reaction medium in turbulent state, specifically by creation of gas bubbles of the carboxylic acid halide herein. Second step may include a flash thermolysis, vacuum thermolysis, thermolysis under stripping with inert gas, and/or a thermolysis at a temperature from >90° C. to 120° C. Third step preferably comprises reacting the alkenone with a nitrogen-containing compound. | 2014-02-20 |
20140051893 | APPARATUS FOR PRODUCING ALCOHOLS FROM OLEFINS - The present invention relates to an apparatus for producing alcohols from olefins, comprising: a hydroformylation reactor wherein aldehydes are produced from olefins; a catalyst/aldehydes separator; a hydrogenation reactor wherein the aldehydes are hydrogenated to produce alcohols; and a distillation column. The hydroformylation reactor is equipped with a distributor plate, which has a broad contact surface for providing sufficient reaction area for reactants such as olefins and synthesis gas, and allows the reaction mixture to circulate and mix sufficiently, which contribute to excellent efficiency in terms of production of aldehydes. In addition, the hydrogenation reactor suppresses sub-reactions to improve the production yield of alcohols. | 2014-02-20 |
20140051894 | Silica Enhanced Support for Hydrogenation Catalysts and Processes for Producing Ethanol - The present invention relates to a catalyst. The catalyst is used for converting acetic acid to ethanol. The catalyst comprises one or more active metals on an alkali metal silicate support or on an alkaline earth metal silicate support, wherein the support further comprises a silica enhancer and a support modifier. | 2014-02-20 |
20140051895 | DEHYDRATION METHOD - The present invention includes a dehydration method comprising the steps of providing a distilled process-target fluid to a water separation membrane device via a heat exchanger; separating the process-target fluid into a dehydrated product and water by using the water separation membrane device; detecting a temperature of any one of the water separation membrane device and the process-target fluid supplied to the water separation membrane device by using a temperature monitoring device; and controlling the temperature of the process-target fluid so that the temperature of the distilled process-target fluid being maintained at a temperature higher than the condensation temperature of the distillate by 5 to 10° C. by using a temperature adjustment device provided in the water separation membrane device. | 2014-02-20 |
20140051896 | Method for Purifying Trans-1,3,3,3-Tetrafluoropropene - Disclosed is a method for purifying a trans-1,3,3,3-tetrafluoropropene, in which a composition containing trans-1,3,3,3-tetrafluoropropene and at least one impurity selected from the group consisting of C | 2014-02-20 |
20140051897 | RENEWABLE JET FUEL BLENDSTOCK FROM ISOBUTANOL - The present invention in its various embodiments is directed to methods for preparing a renewable jet fuel blendstock, and blendstocks prepared by such methods, comprising fermenting a biomass-derived feedstock to form one or more C | 2014-02-20 |
20140051898 | Diesel and Jet Fuels Based on the Oligomerization of Butene - A renewable biofuel based on a highly efficient batch catalysis methodology for conversion of 1-butene to a new class of potential jet fuel blends. By tuning the catalyst and then using the dimer produced, the carbon use is about 95% or greater. This latter point will be particularly important in the future, where the source of raw materials (i.e., biomass/biofeedstock) is limited. | 2014-02-20 |
20140051899 | HYDROCARBON FUEL PRODUCTION METHOD - The present invention provides a method for producing a hydrocarbon fuel, comprising a first step of holding a mixture containing an aliphatic compound produced by algae, and a hydrocarbon solvent in which critical temperature is 90° C. or higher, in a supercritical state, with temperature and pressure adjusted so that a solubility of the aliphatic compound in the hydrocarbon solvent is 15 g or less per 100 g of the hydrocarbon solvent, and then recovering a soluble portion of the aliphatic compound in the hydrocarbon solvent; and a second step of subjecting the soluble portion recovered in the first step to hydrotreatment using a catalyst. | 2014-02-20 |
20140051900 | PROCESS FOR METHANOL COUPLED CATALYTIC CRACKING REACTION OF NAPHTHA USING A MODIFIED ZSM-5 MOLECULAR SIEVE CATALYST - The present invention provides a process for methanol coupled catalytic cracking reaction of naphtha using a modified ZSM-5 molecular sieve catalyst, comprising performing a co-feeding reaction of methanol and naphtha on the modified ZSM-5 molecular sieve catalyst to produce low carbon olefins and/or aromatic hydrocarbons. In the process, the modified ZSM-5 molecular sieve catalyst comprises, in term of weight percent, 25-80 wt % of a ZSM-5 molecular sieve, 15-70 wt % of a binder, and 2.2-6.0 wt % of lanthanum and 1.0-2.8 wt % of phosphorus loaded on the ZSM-5 molecular sieve. The naphtha comprises 63.8-89.5 wt % of saturated chain alkanes and 5.6-29.8 wt % of cyclic alkanes. The naphtha and methanol concurrently pass through the catalyst bed, which are reacted during contacting with the catalyst under a reaction condition of a reaction temperature of 550-670° C., a mass ratio of methanol to naphtha of 0.05-0.8, and a total mass space velocity of naphtha and methanol of 1.0-5 h | 2014-02-20 |
20140051901 | Catalytic Cracking - A process for producing a catalyst additive for an FCC catalytic cracking process, the process comprising the steps of providing an MFI or MEL aluminosilicate having a silicon/aluminium atomic ratio of from 10 to 250; de-aluminating the MFI or MEL aluminosilicate by extracting from 20 to 40 wt % of the alumina therefrom; combining the de-aluminated MFI or MEL aluminosilicate with a binder; and calcining the combination of the de-aluminated MFI or MEL aluminosilicate and the binder at elevated temperature to produce the catalyst additive. | 2014-02-20 |
20140051902 | PROCESS FOR ELIMINATING OR REDUCING PERSISTENT ORGANIC POLLUTANTS CONTAINED IN PARTICLES - A treatment process of persistent organic pollutants contained in particles is provided. Said process includes reacting persistent organic pollutant in particles under hydrothermal conditions in the presence of Fe | 2014-02-20 |
20140051903 | OPTIMIZED PROCESS FOR TREATING WASTE VIA HYDROTHERMAL TREATMENT - The present invention relates to a process for hydrothermal oxidation of organic compounds, optionally with oxidizable inorganic compounds, contained in an aqueous effluent, wherein said aqueous effluent is injected within a tubular reactor wherein the effluent is brought to a supercritical pressure and wherein the temperature of the effluent is gradually increased from its initial temperature up to a supercritical temperature, without any intermediate decrease in temperature, by introducing within said tubular reactor a sufficient amount of oxidizing agent for totally oxidizing the organic compounds and optionally for at least partly oxidizing oxidizable inorganic compounds, the oxidizing agent being introduced in a fractionated way in several points increasingly located downstream, and wherein the composition and/or the concentration of the organic compounds and/or oxidizable organic compounds within the effluent to be treated varies over time, and, upstream from the tubular reactor wherein oxidation is carried out, the TOD of the effluent to be treated is measured and monitored at a value of more than 120 g/L and of less than 250 g/L prior to its injection into the tubular reactor. | 2014-02-20 |
20140051904 | ENERGY APPLICATION APPARATUS - The invention relates to an energy application apparatus for applying energy to an object, wherein the object ( | 2014-02-20 |
20140051905 | STIMULUS GENERATION APPARATUS - There is provided a stimulus generation apparatus including a stimulus generation section which provides a stimulus for promoting fat burning for fat or a satiety center inside a body cavity. | 2014-02-20 |
20140051906 | CHRONIC ELECTROACCUPUNCTURE USING IMPLANTED ELECTRODES - A method of providing an implantable stimulation system to achieve chronic or permanent electrical stimulation of acupuncture points to treat a variety of chronic disorders. | 2014-02-20 |
20140051907 | VENTRICULAR FUNCTION ASSISTING DEVICES AND METHODS OF USE THEREOF - The present invention provides devices and methods for assisting in the ventricular function of a treated heart, and tools for delivering and attaching elements of said devices to the wall of the heart. In general the devices of the invention are designed to assist in the ventricular function of the heart by utilizing elastic, and/or magnetic, elements designed to apply radially and/or tangentially directed forces over the wall of the heart, and/or alter the pressure conditions inside ventricle(s) of the heart. Embodiments of the invention may utilize restrictive elements which may optionally be attached over the heart during the implantation procedure, or at a later time, by changing the mode of operation of an implanted device of the invention. | 2014-02-20 |
20140051908 | Hemodynamic Assist Device - A hemodynamic flow assist device includes a miniature pump, a basket-like cage enclosing and supporting the pump, and a motor to drive the pump. The device is implanted and retrieved in a minimally invasive manner via percutaneous access to a patient's artery. The device has a first, collapsed configuration to assist in implantation and a second, expanded configuration once deployed and active. The device is deployed within a patient's aorta and is secured in place via a self-expanding cage which engages the inner wall of the aorta. The device includes a helical screw pump with self-expanding blades. Also included is a retrieval device to remove the hemodynamic flow assist device once it is no longer needed by the patient. Also included is an arterial closure device to close the artery access point after implantation and removal of the hemodynamic flow assist device. The hemodynamic flow assist device helps to increase blood flow in patients suffering from congestive heart failure and awaiting heart transplant. | 2014-02-20 |
20140051909 | Synchronization Control System - The various embodiments herein relate to systems and methods for controlling the operation of a pulsatile heart assist device in a patient. The systems and methods include utilizing sounds and electrical signals produced by the heart to control the operation of the heart assist device. | 2014-02-20 |
20140051910 | Transport Incubator System Frame with Tank Trays - A transport incubator system includes an incubator, a system frame, and, optionally, supporting components. Supporting components can include a dampening system, slide-out internal compressed gas cylinder storage trays, a monitor mount, handles, strapping points, a chart and hand-held device holder, an electrical control box, a pneumatic control box, an accessory deck, an LED examination light, and a DC distribution component. Methods of using such a transport incubator system are also described. | 2014-02-20 |
20140051911 | Transport Incubator System Frame with Adjustable Handles - A transport incubator system includes an incubator, a system frame, and, optionally, supporting components. Supporting components can include a dampening system, slide-out internal compressed gas cylinder storage trays, a monitor mount, handles, strapping points, a chart and hand-held device holder, an electrical control box, a pneumatic control box, an accessory deck, an LED examination light, and a DC distribution component. Methods of using such a transport incubator system are also described. | 2014-02-20 |
20140051912 | Transport Incubator System Frame With Regulator Mounts - A transport incubator system includes an incubator, a system frame, and, optionally, supporting components. Supporting components can include a dampening system, slide-out internal compressed gas cylinder storage trays, a monitor mount, handles, strapping points, a chart and hand-held device holder, an electrical control box, a pneumatic control box, an accessory deck, an LED examination light, and a DC distribution component. Methods of using such a transport incubator system are also described. | 2014-02-20 |
20140051913 | Transport Incubator System Frame Chart Mount - A transport incubator system includes an incubator, a system frame, and, optionally, supporting components. Supporting components can include a dampening system, slide-out internal compressed gas cylinder storage trays, a monitor mount, handles, strapping points, a chart and hand-held device holder, an electrical control box, a pneumatic control box, an accessory deck, an LED examination light, and a DC distribution component. Methods of using such a transport incubator system are also described. | 2014-02-20 |
20140051914 | GASTRIC BYPASS BAND AND SURGICAL METHOD - The present invention relates to a nano-enhanced device for substance transfer between the device and a tissue. The device comprises a substrate with substantially aligned carbon nanotubes anchored within the substrate, and with at least one end of the carbon nanotubes protruding from the substrate. The protruding nanotube ends may be coated with a drug for delivery of the drug into body tissue. The present invention may be incorporated into an angioplasty catheter balloon or into a patch that is worn on the skin. The carbon nanotubes can be grouped in clusters to effectively form nano-needles which can transfer fluid to or from the subdermal tissue. The nano-needles can be used in conjunction with a sensor to ascertain body fluid information such as pH, glucose level, etc. | 2014-02-20 |
20140051915 | FIXATING MEANS BETWEEN A MESH AND MESH DEPLOYMENT MEANS ESPECIALLY USEFUL FOR HERNIA REPAIR SURGERIES AND METHODS THEREOF - The present invention provides a fixating means adapted for use in hernia repair surgeries in attaching a mesh and mesh deployment means; said fixating means are attached to said mesh deployment means; and fixating means comprising: (a) a first portion coupled to said deployment means; and, (b) a second portion comprising a coil having a predetermined retracted shape; said coil is reconfigurable from a plurality of unretracted positions to a plurality of retracted positions and from said plurality of retracted positions to said plurality of unretracted positions; wherein said attachment between said deployment means and said mesh is obtained by reconfiguration of said coil from at least one of said unretracted positions to at least one of said retracted positions. | 2014-02-20 |
20140051916 | METHOD AND DEVICE FOR TREATING DYSFUNCTIONAL CARDIAC TISSUE - Various methods and devices are provided for reducing the volume of the ventricles of the heart. In one embodiment, a method for reducing the ventricular volume of a heart chamber is provided including the steps of inserting an anchoring mechanism onto dysfunctional cardiac tissue, deploying one or more anchors into the dysfunctional cardiac tissue, raising the dysfunctional cardiac tissue using the anchors, and securing the anchors to hold the dysfunctional cardiac tissue in place. Further, a device for reducing the volume of the ventricles of a heart chamber is provided where the device has one or more clips for placement on dysfunctional cardiac tissue of a heart, one or more anchors for deployment and securement into the dysfunctional cardiac tissue, and a lifting mechanism for raising the one or more anchors and the dysfunctional cardiac tissue. | 2014-02-20 |
20140051918 | LAPAROSCOPIC GASTRIC BAND WITH ACTIVE AGENTS - A gastric banding system is provided which generally includes a gastric band and an active agent, for example, a metabolic agent or satiety inducing agent. The band may be structured to contain the agent and permit controlled release of the agent to the patient while the band is positioned around the stomach. Methods for treating obesity are also provided which include positioning a gastric band on the stomach of a patient and administering a satiety inducing agent to the patient while the gastric band is positioned on the stomach. In one embodiment, the active agent may be contained in a reservoir and dispensed to a portion of the patient's body. | 2014-02-20 |
20140051919 | SELF-ADJUSTING GASTRIC BAND - A self-adjusting gastric band comprises an inflatable portion that includes a fluid such as saline. A reservoir is spaced from the inflatable portion according to a distance related to a wavelength of a peristaltic wave that propagates through the esophageal-gastric junction. A pressure-relief valve is coupled between the inflatable portion and the reservoir and allows an amount of the fluid to pass from the inflatable portion to the reservoir when a first force generates an increased pressure in the inflatable portion. The amount of fluid is released to allow the large bolus to pass through the esophageal-gastric junction. A contracted portion of the peristaltic wave is proximate the reservoir when an expanded portion of the wave is proximate the inflatable portion of the self-adjusting gastric band, to facilitate allowing the amount of the fluid to enter the reservoir. | 2014-02-20 |
20140051921 | METHODS AND SYSTEMS FOR OPTIMIZING VIDEO STREAMING - A method for performing a surgical procedure includes adjusting an encoding configuration of a video encoder in response to receiving an input associated with a change of state of a surgical system performing the surgical procedure, and encoding image data of the surgical procedure captured after the change of state based on the adjusted encoding configuration. | 2014-02-20 |
20140051922 | REAL-TIME GENERATION OF THREE- DIMENSIONAL ULTRASOUND IMAGE USING A TWO-DIMENSIONAL ULTRASOUND TRANSDUCER IN A ROBOTIC SYSTEM - Systems and methods for performing robotically-assisted surgical procedures on a patient enable an image display device to provide an operator with auxiliary information related to the surgical procedure, in addition to providing an image of the surgical site itself. The systems and methods allow an operator to selectively access and reference auxiliary information on the image display device during the performance of a surgical procedure. | 2014-02-20 |
20140051923 | PED-Endoscope Image and Diagnosis Capture System - A personal electronic device (PED)-endoscope image and diagnosis capture system is provided. The system includes a PED adapter having a magnification lens connection side and a PED connection side. A magnification lens is connectable with the lens connection side of the PED adapter. An eyepiece lens coupler is also provided and connects the magnification lens to the endoscope eyepiece. A PED is connected to the PED adapter and includes a processor, a memory and an image capture system with a PED lens. The PED adapter aligns the magnification lens with the PED lens. The processor is configured to activate the image capture system using a remote or voice-activated trigger signal and store captured images in the PED memory. Patient data and examination data can be associated with the images, and the images and data can be transferred from the PED to an electronic medical records system. | 2014-02-20 |